(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 6.17% is not forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 6.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.58%.
Cognex's revenue in 2025 is $971,705,000.On average, 24 Wall Street analysts forecast CGNX's revenue for 2025 to be $167,765,647,049, with the lowest CGNX revenue forecast at $159,167,867,135, and the highest CGNX revenue forecast at $175,139,961,205. On average, 25 Wall Street analysts forecast CGNX's revenue for 2026 to be $180,000,304,626, with the lowest CGNX revenue forecast at $168,603,637,294, and the highest CGNX revenue forecast at $201,285,256,849.
In 2027, CGNX is forecast to generate $195,586,923,183 in revenue, with the lowest revenue forecast at $180,503,098,773 and the highest revenue forecast at $214,357,904,671.